EyePoint Pharmaceuticals, Inc. (EYPT)
NASDAQ: EYPT · IEX Real-Time Price · USD
8.80
-0.05 (-0.56%)
At close: Jul 19, 2024, 4:00 PM
8.88
+0.08 (0.91%)
Pre-market: Jul 20, 2024, 9:29 AM EDT
EyePoint Pharmaceuticals Stock Forecast
Stock Price Forecast
The 5 analysts with 12-month price forecasts for EYPT stock have an average target of 32.8, with a low estimate of 28 and a high estimate of 44. The average target predicts an increase of 272.73% from the current stock price of 8.80.
Analyst Consensus: Strong Buy
Analyst Ratings
The average analyst rating for EYPT stock from 6 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Feb '24 | Mar '24 | Apr '24 | May '24 | Jun '24 | Jul '24 |
|---|---|---|---|---|---|---|
| Strong Buy | 5 | 5 | 5 | 5 | 3 | 3 |
| Buy | 3 | 3 | 3 | 3 | 3 | 3 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 8 | 8 | 8 | 8 | 6 | 6 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Chardan Capital | Chardan Capital | Strong Buy Maintains $28 | Strong Buy | Maintains | $28 | +218.18% | Jun 28, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $30 | Strong Buy | Reiterates | $30 | +240.91% | Jun 27, 2024 |
| Cantor Fitzgerald | Cantor Fitzgerald | Buy Reiterates n/a | Buy | Reiterates | n/a | n/a | Jun 20, 2024 |
| JP Morgan | JP Morgan | Buy Maintains $35 → $32 | Buy | Maintains | $35 → $32 | +263.64% | Jun 4, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains $33 → $30 | Strong Buy | Maintains | $33 → $30 | +240.91% | May 13, 2024 |
Financial Forecast
Revenue This Year
40.07M
from 46.02M
Decreased by -12.93%
Revenue Next Year
13.60M
from 40.07M
Decreased by -66.06%
EPS This Year
-2.38
from -1.82
EPS Next Year
-3.17
from -2.38
Revenue Forecast
| Revenue | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | 57.8M | 25.0M | 48.5M | 91.4M | 562.5M |
| Avg | 40.1M | 13.6M | 9.6M | 70.8M | 319.2M |
| Low | n/a | n/a | n/a | 45.3M | 53.3M |
Revenue Growth
| Revenue Growth | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | 25.5% | -37.5% | 256.7% | 852.9% | 694.7% |
| Avg | -12.9% | -66.1% | -29.5% | 638.3% | 350.9% |
| Low | - | - | - | 372.3% | -24.7% |
EPS Forecast
| EPS | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | -1.95 | -2.44 | -2.58 | -1.79 | 1.95 |
| Avg | -2.38 | -3.17 | -3.32 | -2.53 | 0.60 |
| Low | -2.80 | -4.46 | -3.73 | -3.97 | -1.35 |
EPS Growth
| EPS Growth | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | - | - | - | - | - |
| Avg | - | - | - | - | - |
| Low | - | - | - | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.